Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
Author(s) -
William M. Merritt,
Yvonne G. Lin,
Liz Y. Han,
Aparna A. Kamat,
Whitney A. Spannuth,
Rosemarie Schmandt,
Diana L. Urbauer,
L Pennacchio,
JanFang Cheng,
Alpa M. Nick,
Michael T. Deavers,
Alexandra A. Mourad-Zeidan,
Hua Wang,
Peter P. Mueller,
Marc E. Lenburg,
Joe W. Gray,
Samuel C. Mok,
Michael J. Birrer,
Gabriel López-Berestein,
Robert L. Coleman,
Menashe BarEli,
Anil K. Sood
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0803785
Subject(s) - drosha , dicer , ovarian cancer , medicine , hazard ratio , microrna , small interfering rna , cancer research , cancer , rna interference , microbiology and biotechnology , oncology , biology , rna , gene , genetics , confidence interval
We studied Dicer and Drosha, components of the RNA-interference machinery, in ovarian cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom